Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?
Andréa D. Fuzimoto, Ciro Isidoro
Journal of Traditional and Complementary Medicine (2020) Vol. 10, Iss. 4, pp. 405-419
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
Seshu Vardhan, Suban K. Sahoo
Computers in Biology and Medicine (2020) Vol. 124, pp. 103936-103936
Open Access | Times Cited: 210
Medicinal Plants as Sources of Active Molecules Against COVID-19
Bachir Benarba, Atanasio Pandiella
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 180
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Farhana Rumzum Bhuiyan, Sabbir Howlader, Topu Raihan, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 163
Botanical drugs and supplements affecting the immune response in the time of COVID‐19: Implications for research and clinical practice
Thomas Brendler, Ahmed Al‐Harrasi, Rudolf Bauer, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 6, pp. 3013-3031
Closed Access | Times Cited: 95
Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies
Ahmed A. Zaki, Ahmed Ashour, Sameh S. Elhady, et al.
Journal of Traditional and Complementary Medicine (2021) Vol. 12, Iss. 1, pp. 16-34
Open Access | Times Cited: 89
In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, et al.
Journal of Traditional and Complementary Medicine (2021) Vol. 12, Iss. 1, pp. 35-43
Open Access | Times Cited: 84
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
Panthakarn Rangsinth, Chanin Sillapachaiyaporn, Sunita Nilkhet, et al.
Journal of Traditional and Complementary Medicine (2021) Vol. 11, Iss. 2, pp. 158-172
Open Access | Times Cited: 74
Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?
Douglas Dourado, Danielle Teixeira Freire, Daniel T. Pereira, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111578-111578
Open Access | Times Cited: 71
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
Andréa D. Fuzimoto
Journal of Integrative Medicine (2021) Vol. 19, Iss. 5, pp. 375-388
Open Access | Times Cited: 64
Prediction of COVID-19 manipulation by selective ACE inhibitory compounds of Potentilla reptant root: In silico study and ADMET profile
Yuan Xu, Mahmood Al-Mualm, Ermias Mergia Terefe, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 7, pp. 103942-103942
Open Access | Times Cited: 38
Inhibitory Efficacy of Main Components of Scutellaria baicalensis on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II
Cheng‐Han Lin, Ho-Ju Chang, M. C. Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2935-2935
Open Access | Times Cited: 7
Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection
Anchalee Prasansuklab, Atsadang Theerasri, Panthakarn Rangsinth, et al.
Journal of Traditional and Complementary Medicine (2020) Vol. 11, Iss. 2, pp. 144-157
Open Access | Times Cited: 66
Plant-Based Drugs and Vaccines for COVID-19
Nasir Mahmood, Sarah Bushra Nasir, Kathleen Hefferon
Vaccines (2020) Vol. 9, Iss. 1, pp. 15-15
Open Access | Times Cited: 49
Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells
Seshu Vardhan, Suban K. Sahoo
Journal of Traditional and Complementary Medicine (2021) Vol. 12, Iss. 1, pp. 6-15
Open Access | Times Cited: 40
Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) cultivars using UPLC-MS/MS coupled to chemometric analysis, in vitro study and molecular docking
Reham S. Darwish, Alaa A. El‐Banna, Doaa A. Ghareeb, et al.
Journal of Ethnopharmacology (2022) Vol. 291, pp. 115038-115038
Open Access | Times Cited: 28
Medicinal Plants for Viral Respiratory Diseases: A Systematic Review on Persian Medicine
Mahdie Hajimonfarednejad, Mohadeseh Ostovar, Fatemeh Sadat Hasheminasab, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 16
Identification of antiviral phytochemicals from cranberry as potential inhibitors of SARS-CoV-2 main protease (Mpro)
Jisha Pillai U, L. Cherian, Khushman Taunk, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129655-129655
Closed Access | Times Cited: 6
Non-linear oral bioavailability and clinical pharmacokinetics of high-dose Andrographis paniculata ethanolic extract: relevant dosage implications for COVID-19 treatment
Phanit Songvut, Jaratluck Akanimanee, Tawit Suriyo, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 42-52
Open Access
The activity of indigo carmine against bacteriophages: an edible antiphage agent
Sada Raza, Bartłomiej Bończak, N. Atamas, et al.
Applied Microbiology and Biotechnology (2025) Vol. 109, Iss. 1
Open Access
Alkaloids: Therapeutic Potential against Human Coronaviruses
Burtram C. Fielding, Carlos da Silva Maia Bezerra Filho, Nasser S. M. Ismail, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5496-5496
Open Access | Times Cited: 47
Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19
Rajeshwari Singh, Sumeet Goel, Pascale Bourgeade, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 40, pp. 55925-55951
Open Access | Times Cited: 35
Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives
Howaida I. Abd‐Alla, Dalila Souguir, Mohamed O. Radwan
Archives of Pharmacal Research (2021) Vol. 44, Iss. 11, pp. 903-986
Open Access | Times Cited: 34
Immunomodulatory and antivirus activities of bioactive polysaccharides and structure-function relationship
Qingbin Guo, Xiaojun Huang, Ji Kang, et al.
Bioactive Carbohydrates and Dietary Fibre (2021) Vol. 27, pp. 100301-100301
Closed Access | Times Cited: 33
A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19
Robert L. Chapman, Shridhar V. Andurkar
Medicinal Chemistry Research (2021) Vol. 31, Iss. 1, pp. 40-51
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top